Mimpara and hypercalcaemia Patient Reports February 11, 2012
Mimpara Side Effects Report #5227372-2
Mimpara side effect was reported by a Health Professional from FRANCE on Jan 25, 2007. Female patient, 74 years of age, was diagnosed with pre-existing disease and was treated with Mimpara. After drug was administered, patient experienced the following side effects: asthenia, confusional state, hypercalcaemia, metabolic disorder
, muscular weakness, tremor. Mimpara dosage: unknown. Patient was hospitalized. Patient recovered.Mimpara Side Effects Report #5064480-3
Mimpara side effect was reported by a Consumer or non-health professional from FRANCE on Oct 21, 2005. Male patient, 25 years of age, was diagnosed with hyperparathyroidism secondary and was treated with Mimpara. After drug was administered, patient experienced the following side effects: dehydration, hypercalcaemia, hypercalciuria. Mimpara dosage: unknown. During the same period patient was treated with CORTICOSTEROIDS, IMMUNOGLOBULINS, CYCLOSPORINE, MYCOPHENOLATE MOFETIL. Patient was hospitalized. Patient recovered.
Mimpara Side Effects Report #4816674-7
Mimpara side effect was reported by a Consumer or non-health professional from FRANCE on Oct 21, 2005. Male patient, 25 years of age, was diagnosed with hyperparathyroidism secondary and was treated with Mimpara. After drug was administered, patient experienced the following side effects: hypercalcaemia, hypercalciuria. Mimpara dosage: unknown. Patient was hospitalized. Patient recovered.
Mimpara Side Effects Report #4819731-4
Mimpara side effect was reported by a Consumer or non-health professional from FRANCE on Oct 21, 2005. Male patient, 25 years of age, was diagnosed with hyperparathyroidism secondary and was treated with Mimpara. After drug was administered, patient experienced the following side effects: blood parathyroid hormone increased, hypercalcaemia, hypercalciuria. Mimpara dosage: unknown. Patient was hospitalized. Patient recovered.
Mimpara Side Effects Report #4902453-9
Mimpara side effect was reported by a Consumer or non-health professional from FRANCE on Oct 21, 2005. Male patient, 25 years of age, was diagnosed with hyperparathyroidism secondary and was treated with Mimpara. After drug was administered, patient experienced the following side effects: dehydration, hypercalcaemia, hypercalciuria. Mimpara dosage: unknown. Patient was hospitalized. Patient recovered.
Mimpara Side Effects Report #5214350-2
Mimpara side effect was reported by a Physician from BELGIUM on Jan 12, 2007. Female patient, weighting 134.5 lb, was diagnosed with hyperparathyroidism secondary and was treated with Mimpara. After drug was administered, patient experienced the following side effects: eating disorder
, gastrointestinal obstruction, hypercalcaemia, vomiting. Mimpara dosage: unknown. During the same period patient was treated with ZANTAC, ASAFLOW, NITROGLYCERIN, RENAGEL, TRAMADOL, DUPHALAC, BENSERAZIDE HYDROCHLORIDE, AMITRIPTYLINE HYDROCHLORIDE. Patient was hospitalized. Patient died on 10/07/2006.Mimpara Side Effects Report #5231720-7
Mimpara side effect was reported by a Physician from BELGIUM on Jan 28, 2007. Female patient, weighting 134.5 lb, was diagnosed with hyperparathyroidism secondary and was treated with Mimpara. After drug was administered, patient experienced the following side effects: eating disorder
, gastrointestinal obstruction, hypercalcaemia, vomiting. Mimpara dosage: unknown. During the same period patient was treated with ZANTAC, ASAFLOW, NITROGLYCERIN, RENAGEL, TRAMADOL, DUPHALAC, BENSERAZIDE HYDROCHLORIDE, AMITRIPTYLINE HYDROCHLORIDE. Patient was hospitalized and became disabled. Patient died on 10/07/2006.Mimpara Side Effects Report #5176377-9
Mimpara side effect was reported by a Physician from BELGIUM on Dec 07, 2006. Female patient, weighting 134.5 lb, was diagnosed with hyperparathyroidism secondary and was treated with Mimpara. After drug was administered, patient experienced the following side effects: eating disorder
, gastrointestinal obstruction, hypercalcaemia, infarction. Mimpara dosage: unknown. During the same period patient was treated with ZANTAC, ASAFLOW, NITROGLYCERIN, RENAGEL, TRAMADOL, DUPHALAC. Patient was hospitalized. Patient died on 10/07/2006.
Mimpara and hypercalcaemia 